PET Overview

A positron emission tomography (PET) scan is an imaging test that shows organs and tissues at work. It uses a safe, injectable radioactive substance called a radiotracer along with a PET scanner, which detects cells absorbing large amounts of the tracer — a sign of potential disease. Because it's tracking activity rather than just structure, PET can measure vital functions like blood flow, oxygen use, and metabolism, and can catch disease at very early stages.

How it works

A radiotracer is built from a carrier molecule, such as a sugar, attached to a radioactive label like Technetium-99m or Fluorine-18. The carrier guides the label to targeted tissue, and radioactivity accumulates wherever biological activity is highest. As the tracer moves through the bloodstream, it's absorbed differently by healthy versus diseased cells — cancer cells or other highly active tissue tend to absorb more, creating "hot spots" the scanner can detect. Whatever isn't absorbed is naturally flushed out through urine. A PET scan is often combined with a CT scan, known as PET/CT, pairing PET's activity data with CT's detailed anatomy.

Radiotracer dose

For a standard adult scan using the most common tracer, FDG, doctors typically inject 10 to 20 millicuries (about 370 to 740 megabecquerels). The exact dose is calculated by nuclear medicine technologists based on body weight, balancing image quality against minimizing radiation exposure. The tracer itself contributes about 4 to 8 millisieverts of radiation; combined with the CT portion of a PET/CT scan, the total effective dose is usually 10 to 25 millisieverts — comparable to roughly 2 to 3 years of natural background radiation. A prepared radiotracer typically has a shelf life of about 8 hours.

Common types of PET tracers

Tracer Used for
FDG (fluorodeoxyglucose) The most common PET tracer; shows how cells use sugar, which helps find or stage cancers that tend to consume more sugar
Gallium (e.g. gallium-68, DOTATATE) Used to evaluate certain tumors or infections
Rubidium Commonly used to assess blood flow to the heart
Other specialized tracers Amyloid tracers for brain conditions like Alzheimer's disease; fluciclovine (Axumin) for prostate cancer

When a PET scan is ordered

During active cancer treatment, scans are typically performed after every 2 to 3 treatment cycles — roughly every 6 to 12 weeks — to assess response. After treatment ends, surveillance scans are usually done every 3 to 6 months at first, gradually spacing out to once or twice a year as recurrence risk drops. Medicare typically covers up to three follow-up PET scans per tumor type after initial treatment, though more can be covered with documentation of medical necessity. Scans are generally not scheduled more than once on the same day.

Preparing for a PET scan

What to expect during the scan

The full process takes about two hours: up to 60 minutes for the tracer to be absorbed, about 30 minutes for the scan itself, and some additional time while the technologist checks image quality.

Risks and side effects

PET scans are generally safe and rarely cause problems. The radiation dose is low and doesn't stay in the body long — drinking plenty of water afterward helps flush it out faster. Risk is mainly a concern in a few specific situations: pregnancy or breastfeeding, since radiation could affect a fetus or pass through breast milk; a rare allergic reaction to the tracer or to CT contrast dye; and diabetes, which can affect how the body absorbs the sugar-based tracer and may require diet or medication adjustments beforehand.

After the scan

Most people resume normal activities right away. The tracer clears the body within a few hours, and drinking fluids helps speed that up. Mild discomfort at the injection site is possible but uncommon. A radiologist trained in PET imaging reviews the results and sends a report to the ordering provider, typically within 24 to 48 hours.

Understanding the results

Results can also show how a disease is progressing or how well a treatment is working. Contact your healthcare provider if you notice dizziness, nausea, difficulty breathing, or worsening pain at the injection site after the scan.